Table 4.
Distribution of patients by pathologic characteristics
| Characteristic | n | % |
|---|---|---|
| pTstage | ||
| pT2a | 6 | 18% |
| pT2b | 1 | 3% |
| pT2c | 11 | 32% |
| pT3a | 2 | 6% |
| pT3b | 13 | 38% |
| pT4 | 1 | 3% |
| Gleason Score | ||
| 6 | 3 | 9% |
| 7 | 17 | 50% |
| ≥8 | 9 | 26% |
| Pathologic Node Status | ||
| N+ | 0 | 0% |
| N- | 29 | 85% |
| Nx | 5 | 15% |
| Margin Status | ||
| Positive | 9 | 26% |
| Negative | 25 | 74% |
| Bladder Neck Invasion | ||
| Present | 1 | 3% |
| Absent | 33 | 97% |
| Seminal Vesicle Invasion | ||
| Present | 12 | 35% |
| Absent | 22 | 65% |
| Extra-capsular Extension | ||
| Present | 13 | 38% |
| Absent | 21 | 62% |
| Calculated Tumor Volume | ||
| ≤3.0cc | 9 | 26% |
| 3.1-5.0cc | 8 | 24% |
| 5.0-9.0cc | 10 | 29% |
| >9.0cc | 7 | 21% |
Percentages may not add up to 100% due to missing data.